Home > Boards > US OTC > Biotechs >

Know Labs, Inc. (KNWN)

KNWN RSS Feed
Add KNWN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/13/2022 11:36:43 PM - Followers: 67 - Board type: Free - Posts Today: 0

About Know Labs, Inc.
Know Labs, Inc. (f/k/a Know Labs Incorporated) is a public company whose shares trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. The Company refers to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio-RFID are used to identify, detect, or diagnose substance markers or biomarkers that may be invisible to the human eye. ChromaID and Bio-RFID scanner modules can be integrated into a variety of mobile or bench-top form factors. This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or large and expensive lab-based tests. For more information on Know Labs, visit the company’s website at http://bit.ly/knowlabs

Overview
Historically, the Company focused on the development of our proprietary ChromaID technology. Using light from low-cost LEDs (light emitting diodes) we map the color of substances, fluids and materials and with our proprietary processes we can authenticate, identify and diagnose based upon the color that is present. The color is both visible to us as humans but also outside of the humanly visible color spectrum in the near infra-red and near ultra-violet and beyond. Our ChromaID scanner sees what we like to call “Nature’s Color Fingerprint.”  Everything in nature has a unique color identifier and with ChromaID we can see it, and identify, authenticate and diagnose based upon the color that is present.  Our ChromaID scanner is capable of uniquely identifying and authenticating almost any substance or liquid using light to create, record and detect its unique color signature. We will continue to develop and enhance our ChromaID technology and extend its capacity. More recently, we have focused upon extensions and new inventions that are derived from and extend beyond our ChromaID technology.   We call this technology Bio-RFID.  The rapid advances made with our Bio-RFID technology in our laboratory have caused us to move quickly in to the commercialization phase of our Company as we work to create revenue generating products for the marketplace.  
 
ChromaID and Bio-RFID:  Foundational Platform Technologies
Our ChromaID and Bio-RFID technologies provide a platform upon which a myriad of applications can be developed.  As platform technologies, they are analogous to a smartphone, upon which an enormous number of previously unforeseen applications have been developed.  ChromaID and Bio-RFID technologies are “enabling” technologies that bring the science of electromagnetic energy to low-cost, real-world commercialization opportunities across multiple industries. The technologies are foundational and, as such, the basis upon which the Company believes a significant business can be built.
 
As with other foundational technologies, a single application may reach across multiple industries. The ChromaID technology can, for example effectively differentiate and identify different brands of clear vodkas that appear identical to the human eye. By extension, this same technology can identify pure water from water with contaminants present. It can provide real time detection of liquid medicines such as morphine that have been adulterated or compromised. It can detect if jet fuel has water contamination present. It could determine when it is time to change oil in a deep fat fryer. These are but a few of the potential applications of the ChromaID technology based upon extensions of its ability to identify different clear liquids.
 
Similarly, the Bio-RFID technology can non-invasively identity the presence and quantity of glucose in the human body.  By extension, there may be other molecular structures which this same technology can identity in the human body which, over time, the Company will focus upon. They may include the monitoring of drug usage or the presence of illicit drugs.  They may also involve identifying hormones and various markers of disease. 
 
The cornerstone of a company with a foundational platform technology is its intellectual property.  We have pursued an active intellectual property strategy and have been granted 12 patents.  We currently have 20 patents pending.  We possess all right, title and interest to the issued patents.


About Our Team

Phil Bosua
Chief Executive Officer

Phil Bosua is an internationally recognized inventor and innovator. His expertise in lighting lead him to found LIFX (www.lifx.com) where he created the world’s first commercial smart light bulb. The 2012 crowdsourcing launch of his smart light bulb raised $1.3 million in six days and attracted $12 million in funding from Sequoia Capital (www.sequoiacap.com). This groundbreaking invention earned him the prestigious Edison Gold Award (www.edisonawards.com) presented by Elon Musk to innovators who create products that have a positive impact on the world. Bosua also founded RAAI, Inc., where he continued his innovative creation of new uses of light. Bosua said, “The time I have spent in the Visualant lab working on advancing their technology has been some of the most scintillating moments of my career. Ron Erickson and Visualant have provided support to allow me and the lab team to explore new products and discover new technologies. I’m excited by the technology platform we are creating, knowing that it will benefit millions of people around the world and be equally as good for our shareholders.”

LinkedIn: http://bit.ly/2yeBNR9
Press Release: http://bit.ly/2HJRZsJ


Ronald P. Erickson
CFO, President and Chairman of the Board.

Mr. Erickson has been a director and officer of the Company since April 24, 2003. He currently serves as the Company's Chairman, Chief Executive Officer and President. He was appointed to the positions of CEO and President on November 10, 2009. Earlier, he was appointed President and Chief Executive Officer of the Company on September 29, 2003, and resigned from this position on August 31, 2004 at which time he was appointed Chairman of the Board. A seasoned executive with more than 30 years of experience in the high technology, telecommunications, micro-computer, and digital media industries, Mr. Erickson was the founder of Know Labs. In addition to his Know Labs responsibilities he also serves as Chairman of ivi, Inc. a streaming media company and eCharge Corporation an Internet based transaction processing company. He is formerly Chairman, CEO and Co-Founder of Blue Frog Media, a mobile media and entertainment company; Chairman, CEO and Co-founder of GlobalTel Resources, a provider of telecommunications services; Chairman, Interim President and CEO of Egghead Software, Inc. the large software reseller where he was an original investor; Chairman and CEO of NBI, Inc.; and Co-founder of MicroRim, Inc. the database software developer. Earlier, Mr. Erickson practiced law in Seattle and worked in public policy in Washington, DC and New York, NY. Additionally, Mr. Erickson has been an angel investor and board member of a number of public and private technology companies. Mr. Erickson has a BA from Central Washington University, a MA from the University of Wyoming and a JD from the University of California, Davis. He is licensed to practice law in the State of Washington and the District of Columbia.

LinkedIn: http://bit.ly/2t2oE7T


Bill Owens
Know Labs Board of Directors

Admiral Owens is currently the co-founder and executive chairman of Red Bison Advisory Group, a company which identifies opportunities with proven enterprises in China, the Middle East, and the United States and creates dynamic partnerships focusing on: natural resources (oil, gas and fertilizer plants), real estate, and information and communication technology. Most recently, he was the chairman of the board of CenturyLink Telecom, the third largest telecommunications company in the United States and was on the advisory board of SAP USA. Owens serves on the board of directors at Wipro Technologies and is a director of the following private companies: Humm Kombucha, a beverage company and Versium. Owens is on the advisory board of the following private companies: Healthmine, Platform Science, Sarcos, Sierra Nevada Corporation, and Vodi. Owens is on the board of trustees at EastWest Institute, Seattle University, and an advisor to the Fiscal Responsibility Amendment (CFFRA) Association which aims to establish a balanced budget amendment to the US Constitution. He is also a member of the Council of Foreign Relations.

LinkedIn: http://bit.ly/2K6DJwx
Press Release: http://bit.ly/2JzG7PO


CONTACT US

Know Labs, Inc.

Jordyn Theisen, Ph. 206-903-1351
Email: jordyn@knowlabs.co

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/KNWN/company-info
Ticker: $KNWN
OTC Market Tier: OTCQB
CIK code: 0001074828
Company name: Know Labs, Inc.
Company website: http://bit.ly/knowlabs
Incorporated In: NV, USA

##### recent news/filings

Latest filings: http://www.otcmarkets.com/stock/KNWN/filings
Latest financials: http://www.otcmarkets.com/stock/KNWN/financials
Latest news: http://www.otcmarkets.com/stock/KNWN/news - http://finance.yahoo.com/q/h?s=KNWN+Headlines
Corporation WIKI:
Corporate website internet archive: http://bit.ly/knowlabs

 

KNWN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KNWN News: Amended Current Report Filing (8-k/a) 05/05/2022 01:26:37 PM
KNWN News: Amended Current Report Filing (8-k/a) 04/05/2022 12:50:13 PM
KNWN News: Current Report Filing (8-k) 04/05/2022 07:31:56 AM
KNWN News: Current Report Filing (8-k) 03/08/2022 04:01:27 AM
KNWN News: Statement of Changes in Beneficial Ownership (4) 03/03/2022 11:04:41 AM
PostSubject
#3278   Why doesnt KNWN hire an IR firm or RMacchio 05/13/22 11:36:43 PM
#3277   Really dead in here. Why doesnt KNWN namtae 05/13/22 11:35:05 AM
#3276   Podcast - nothing new Rickilbe 05/12/22 04:20:09 PM
#3275   FYI - Rockley Photonics Holdings tim00mike 04/24/22 06:41:28 PM
#3274   Foundational parents big news Predictive health here we come. https://finance slunj 04/05/22 09:31:26 AM
#3273   Know Labs with an update for 2022! Hard Rickilbe 03/08/22 12:47:51 PM
#3272   Thanks tim00mike... THIS VIDEO IS POWERFUL... it ROCKTHE WORLD 02/15/22 08:01:34 AM
#3271   Bio-RFID Explainer and Other Potential Diagnostics Applications tim00mike 02/14/22 08:38:48 PM
#3270   derp DollarSquad 02/10/22 08:41:19 PM
#3267   This isn’t a ride app that’s easily replicated. slunj 02/09/22 12:20:04 PM
#3266   They first announced seeking FDA approval on the RMacchio 02/09/22 11:58:03 AM
#3265   You don't understand how long it takes to marcg 02/09/22 08:55:54 AM
#3264   “Buy” rating and price target of $7 mantix 02/08/22 10:15:44 PM
#3263   What you call "Nay-Sayers" are mostly frustrated investors RMacchio 02/08/22 02:25:05 PM
#3262   FULL 13 page report addressing all aspects of ss0722 02/08/22 01:20:33 PM
#3261   https://biotuesdays.com/2022/02/08/dawson-james-starts-know-labs-at-buy-pt-7/ Rickilbe 02/08/22 12:36:52 PM
#3260   First time I have seen any Stock Analyst fekman 02/08/22 12:02:29 PM
#3259   Nay-sayers went nay-night like roaches. slunj 02/08/22 11:29:20 AM
#3258   KNWN was started at Dawson James with a marcg 02/08/22 09:24:53 AM
#3257   Great article slunj 01/31/22 10:51:45 AM
#3256   Know Labs: Little-Known But Highly Capable Company In tim00mike 01/31/22 10:17:09 AM
#3255   Wall Street doesn't like RKLY. marcg 01/27/22 04:51:14 PM
#3254   More NFT sales will move that up. Regis999 01/27/22 12:30:37 PM
#3253   KNWN has a cash runway to the end marcg 01/27/22 10:12:26 AM
#3252   Discord wasn't used until today. Their responses to Tsponberg 01/26/22 01:03:06 PM
#3251   Knowlabs joins Discord. Open forum for questions. Created Tsponberg 01/26/22 12:58:30 PM
#3250   Form 4 Purchase Regis999 01/25/22 07:26:28 PM
#3249   "but it's not as good" RMacchio 01/23/22 09:33:56 PM
#3248   "but it's not as good" - posters on this board DollarSquad 01/23/22 07:23:37 PM
#3247   Rockley Photonics Holdings has announced the successful completion tim00mike 01/23/22 12:36:10 PM
#3246   Wonder if this changes the 'affordability' plug? DollarSquad 01/22/22 08:22:26 PM
#3245   Medicare Expands Continuous Glucose Monitor (CGM) Coverage tim00mike 01/22/22 12:09:32 PM
#3244   Crash and Burn DollarSquad 01/21/22 01:19:31 PM
#3243   What is going on with this stock... almost RMacchio 01/21/22 11:59:49 AM
#3242   Exactly,Rockley is indeed a hedge. Tsponberg 01/21/22 11:08:02 AM
#3241   I actually have a fairly large position in RMacchio 01/21/22 08:19:44 AM
#3240   I agree Knowlabs is essentially the "Tricorder". Medical Tsponberg 01/21/22 01:51:49 AM
#3239   One reason for the market cap discrepancy is marcg 01/20/22 07:37:08 AM
#3238   Fair enough. Question: Does the market agree with DollarSquad 01/19/22 06:40:13 PM
#3237   That's fantastic news! THANKS! ROCKTHE WORLD 01/19/22 08:21:20 AM
#3236   Quote: "Just because they are using photonic technology KnowMercy 01/18/22 07:04:08 PM
#3235   Rockley has technology similar to DiaMonTech. DiaMonTech's Mean RMacchio 01/18/22 05:45:24 PM
#3234   Agreed what a great point. I believe slunj 01/18/22 01:57:13 PM
#3233   Touche. Thank you for bringing some real knowledge marcg 01/18/22 10:52:40 AM
#3230   Rockley, Dexcom, Abbott Labs Blah, Blah, Blah, Blah. KnowMercy 01/17/22 07:22:31 PM
#3229   Great news. slunj 01/17/22 12:27:25 PM
#3228   The top 10 M&A targets in medtech for GeorgioD 01/16/22 05:45:46 PM
#3227   Thanks for the powerful insight Mark with a C DollarSquad 01/15/22 12:01:59 PM
#3225   Yes sir. Erickson and Phil have spent DollarSquad 01/14/22 08:26:54 PM
#3224   Babbage: The smartwatch will see you now tim00mike 01/14/22 11:48:46 AM
PostSubject
Consent Preferences